Colonic disorder
MONDO:0003409Pathological processes in the colon region of the large intestine (intestine, large).
Also known as: colon disease, colon disease or disorder, disease of colon, disease or disorder of colon, disorder of colon
1256 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New COVID-19 booster studied for vulnerable patients
⭐️ VACCINE ⭐️ CompletedThis study tested a Novavax COVID-19 booster vaccine in 21 people with weakened immune systems due to inflammatory bowel disease or organ transplants. The goal was to see if the booster improved antibody levels and immune protection against COVID-19. Participants had already rece…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:55 UTC
-
Could a cup of green tea keep colon cancer away?
Disease control CompletedThis pilot study tests whether a purified green tea extract called EGCG can help prevent colon cancer from coming back after surgery. 51 patients who had their colon cancer removed took either the extract or a placebo. Researchers are checking for changes in DNA methylation, a ma…
Phase: EARLY_PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Poop pills from different donors: a new hope for ulcerative colitis?
Disease control CompletedThis study tested fecal microbiota transplantation (FMT) from different donors to treat ulcerative colitis, a type of inflammatory bowel disease. Researchers gave 102 patients a one-time colonoscopic infusion of fresh fecal bacteria from healthy donors. The goal was to see if don…
Phase: NA • Sponsor: First Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Vitamin d may unlock iron absorption in IBD patients
Disease control CompletedThis study investigates whether giving vitamin D supplements to adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who also have low vitamin D levels can improve their iron status. Participants take high-dose vitamin D3 weekly for 8 weeks, then a lower…
Phase: PHASE4 • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Stool transplants via stoma show promise for treating Post-Surgery colon inflammation
Disease control CompletedThis study tests whether giving patients their own stool bacteria through a temporary stoma can reduce inflammation in the unused part of the colon, a condition called diversion colitis. Sixty-six people with rectal cancer who have a temporary ileostomy will receive either a dail…
Phase: NA • Sponsor: Yongjian Liao • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New device aims to simplify bowel surgery
Disease control CompletedThis study is testing a new device called SEGER IDEA™ that helps surgeons close openings in the bowel during keyhole surgery. It is the first time this device is being used in humans. Ten adults having certain types of bowel surgery will take part. The main goal is to see if the …
Phase: NA • Sponsor: Seger Surgical Solutions • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail aims to make inoperable abdominal cancers operable
Disease control CompletedThis phase 2 trial tested a combination of two drugs—paclitaxel (given intravenously and directly into the abdomen) and oral nilotinib—in 21 adults with cancers that had spread to the lining of the abdomen and could not be surgically removed. The goal was to see if the treatment …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New antibody aims to calm ulcerative colitis when other treatments fail
Disease control CompletedThis phase 2 trial tests whether OSE-127, an antibody that blocks a key immune signal, can reduce disease activity in people with moderate to severe ulcerative colitis who have not responded to or cannot tolerate previous treatments. Participants are randomly assigned to receive …
Phase: PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can adding cetuximab to chemotherapy prevent colon cancer return?
Disease control CompletedThis large phase III trial studied whether adding the targeted drug cetuximab to standard chemotherapy after surgery helps prevent cancer from coming back in patients with stage III colon cancer. Over 3,300 patients took part, and the study focused on those with a specific geneti…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a structured chat with a nurse boost medication adherence in IBD?
Disease control CompletedThis trial tests whether a nurse-led education program, based on the Health Belief Model, can improve treatment adherence in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are receiving anti-TNF therapy. The program aims to address patients' co…
Phase: NA • Sponsor: Izmir Katip Celebi University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control CompletedThis early-phase trial tested an experimental drug called KVA12123, given alone or with the immunotherapy Keytruda, in 40 adults with advanced solid tumors (like lung, breast, or colon cancer) that had stopped responding to standard treatments. The main goals were to check safety…
Phase: PHASE1, PHASE2 • Sponsor: Kineta Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could tempeh and vitamin d ease IBD symptoms?
Disease control CompletedThis study tested whether taking tempeh powder (a source of isoflavones) and vitamin D3 daily for 8 weeks could improve vitamin D levels, reduce inflammation, and boost quality of life in people with inflammatory bowel disease (IBD). Fifty adults with ulcerative colitis or Crohn'…
Phase: NA • Sponsor: Indonesia University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Prepping the body and mind before colon cancer surgery may cut recovery risks
Disease control CompletedThis trial tests whether a program of exercise, nutrition advice, and psychological support—started four weeks before surgery and continued afterward—can reduce complications in people having colon cancer surgery. Participants are adults over 40 with non-metastatic colon cancer w…
Phase: NA • Sponsor: Universidad de Granada • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New gut bacteria therapy shows promise for colitis
Disease control CompletedThis early-stage study tested a new treatment called MB310 in 29 adults with mild-to-moderate ulcerative colitis. The main goal was to see if it is safe and how well it takes hold in the body. Participants received either MB310 or a placebo, and researchers monitored side effects…
Phase: PHASE1 • Sponsor: Microbiotica Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug targets urgent bathroom needs in colitis patients
Disease control CompletedThis study tested the drug mirikizumab in 172 adults with moderate-to-severe ulcerative colitis who still had bowel urgency despite other treatments. The main goal was to see if the drug reduces the sudden, urgent need to use the bathroom. Participants were followed for 36 weeks …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Seaweed supplement may help leaky gut in bowel disorders
Disease control CompletedThis study tested whether a seaweed-derived supplement called Aquamin® can reduce gut permeability (often called 'leaky gut') in people with ulcerative colitis, irritable bowel syndrome with diarrhea, and healthy volunteers. Thirty-five adults took Aquamin capsules for 90 days. R…
Phase: PHASE2 • Sponsor: James Varani • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Real-World study checks how well tofacitinib controls ulcerative colitis
Disease control CompletedThis completed observational study looked at how well the drug tofacitinib works for people with ulcerative colitis in everyday Swedish clinics. Researchers used a national registry to track disease remission and whether patients stayed on the medication. The study included 102 p…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug shows promise for kids with severe bowel disease
Disease control CompletedThis study tested the drug mirikizumab in 63 children aged 2 to 17 with moderate-to-severe ulcerative colitis, a chronic bowel disease. The goal was to see if the drug could help control the disease and improve symptoms. All children received the drug, and researchers measured re…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Antibody therapy aims to keep colon cancer from returning
Disease control CompletedThis phase III trial tested whether adding a monoclonal antibody called edrecolomab to surgery helps people with stage II colon cancer live longer or stay cancer-free longer. About 2,100 participants were randomly assigned to receive either the antibody or no additional treatment…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Simple arm exercise may boost lung recovery after colon cancer surgery in seniors
Disease control CompletedThis study tested whether a 20-minute arm cycling exercise, done twice daily for five days, could improve lung function and recovery in 60 elderly patients after colon cancer surgery. Participants also received standard physical therapy. The goal was to see if the arm exercise co…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a common arthritis pill tame Chemo's worst side effect?
Disease control CompletedThis study tested whether adding the arthritis drug Celebrex to an experimental chemo drug called EPO906 could reduce severe diarrhea in people with advanced colorectal cancer. The trial enrolled 75 patients who had already tried other treatments. The first phase found the safest…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug combo tested for tough cancers
Disease control CompletedThis early-stage trial tested a new drug called AZD6244 combined with standard chemotherapies in 140 people with advanced solid tumors (breast, colon, lung, melanoma, kidney). The main goal was to see if the combination is safe and tolerable, and to find the best dose. Researcher…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can an arthritis drug boost chemo for colon cancer?
Disease control CompletedThis study tested whether adding the anti-inflammatory drug celecoxib to standard FOLFOX chemotherapy helps prevent cancer from returning in people with stage III colon cancer after surgery. Over 2,500 participants were randomly assigned to receive either celecoxib or a placebo a…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New device could spare colon cancer patients from temporary stoma
Disease control CompletedThis study tested a temporary device called Colovac 2 in 24 people undergoing colon cancer surgery. The device is placed inside the bowel to protect the surgical connection while it heals, potentially avoiding the need for a temporary stoma. Researchers checked if the device stay…
Phase: NA • Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Vedolizumab safety check in kids with IBD shows promise
Disease control CompletedThis study looked at the long-term safety of vedolizumab, a biologic drug given by IV, in 59 children with ulcerative colitis or Crohn's disease. Participants had already completed a previous study and continued treatment to monitor for side effects. The goal was to see if the dr…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New registry shows promise for microwave ablation in liver cancer spread
Disease control CompletedThis registry followed 500 adults with colorectal cancer that spread to the liver. All were treated with a microwave ablation device that uses heat to destroy tumors. The goal was to see how well the device controls tumors locally over 12 months and to track any side effects. The…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug shows promise for keeping ulcerative colitis in check
Disease control CompletedThis study tested whether mirikizumab can help people with moderate to severe ulcerative colitis stay in remission (symptom-free) after they had already responded to an initial treatment. About 1,300 adults who completed a prior induction study were randomly assigned to receive m…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for kids with severe colitis: drug shows promise in major trial
Disease control CompletedThis study tested a drug called ustekinumab in 112 children with moderate-to-severe ulcerative colitis, a condition causing inflammation in the colon. The goal was to see if the drug could reduce symptoms like diarrhea and bleeding and help the colon heal. Children first received…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Which laxative cleans the colon best? new study aims to find out
Disease control CompletedThis study compared two low-volume laxatives used to clean the colon before a colonoscopy: one liter of polyethylene glycol with ascorbate (PEG1A) and sodium picosulfate with magnesium citrate (PSCM). The goal was to see which one provides a higher quality colon cleansing, which …
Phase: PHASE4 • Sponsor: Parc de Salut Mar • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental COM902 drug shows promise in early cancer trial
Disease control CompletedThis early-phase study tested an experimental drug called COM902, alone or with other drugs, in 94 people with advanced cancers like ovarian, lung, and colon cancer. The main goal was to check safety and find the right dose. Researchers also looked for early signs that the drug m…
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug candidate CBX-12 tested in patients with Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, breast, or colon cancer) that had stopped responding to standard therapies. The main goals were to check the drug's safety, find the best dose, and see if it could sh…
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a common arthritis drug tame rare immune disease Flare-Ups?
Disease control CompletedThis study tested the drug tofacitinib (Xeljanz) in 10 adults with chronic granulomatous disease (CGD) who had ongoing inflammation in the gut, skin, or lungs. Participants took the pill daily for 3 months to see if it was safe and could help control symptoms. The goal was to fin…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New stitching trick may improve colon cancer surgery
Disease control CompletedThis study tested a new way to reconnect the colon after removing a cancerous section using a robot. The technique uses a special double purse-string stitch and a single stapler. Thirty-nine patients with sigmoid colon cancer were included, and the study looked at how well the te…
Phase: NA • Sponsor: Vejle Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common cholesterol drug ease ulcerative colitis?
Disease control CompletedThis study tested whether adding fenofibrate, a drug typically used for high cholesterol, to the standard treatment mesalamine can improve symptoms and quality of life in people with mild-to-moderate ulcerative colitis. The trial enrolled 60 adults and measured changes in disease…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New daily pill aims to keep ulcerative colitis in check
Disease control CompletedThis study tested a daily pill called ABX464 (obefazimod) as a long-term maintenance therapy for people with moderate to severe ulcerative colitis. 217 patients who completed a prior 16-week induction study took the drug for up to 96 weeks. The main goal was to see how many patie…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for Tough-to-Treat colon cancer?
Disease control CompletedThis study tested an experimental drug called CTX-009 in 49 adults with metastatic colorectal cancer that had worsened after two or three prior treatments. The goal was to see if the drug could shrink tumors or stop them from growing. Results will help determine if further testin…
Phase: PHASE2 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Home test for gut inflammation could cut flares in ulcerative colitis
Disease control CompletedThis study tested whether people with ulcerative colitis can use a home stool test to catch inflammation early and prevent symptom flares. Over 700 adults in remission used a smartphone-based test kit to measure calprotectin levels. The goal was to see if this proactive monitorin…
Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Washing therapy dogs may keep hospital germs away from kids
Disease control CompletedThis study tested whether cleaning therapy dogs with a special disinfectant (chlorhexidine) before hospital visits could reduce the spread of harmful germs to children. The trial involved 45 children aged 3 to 17 who interacted with therapy dogs. Researchers checked if the cleani…
Phase: PHASE4 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for kids with severe gut disease: drug shows promise in remission
Disease control CompletedThis study tested a medicine called vedolizumab in 121 children with moderate to severe ulcerative colitis, a condition causing inflammation and pain in the gut. The goal was to see if the drug could help children achieve remission, meaning their symptoms improve and tests show l…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could a common Anti-Inflammatory pill boost biologic therapy for ulcerative colitis?
Disease control CompletedThis study looked at whether adding mesalazine (a standard anti-inflammatory drug) to biologic treatments like infliximab or vedolizumab helps people with moderate to severe ulcerative colitis achieve endoscopic remission (healing of the gut lining). The trial enrolled 438 adults…
Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New way to deliver c. diff treatment: through a colonoscopy
Disease control CompletedThis study tested a treatment called RBX2660 (REBYOTA) for people with recurrent Clostridioides difficile infection. The treatment is made from healthy human stool bacteria and was given during a colonoscopy. The goal was to see if this delivery method is safe and works well. For…
Phase: PHASE3 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Exercise program tested to keep colon cancer at bay
Disease control CompletedThis study tested whether a 3-year physical activity program could help prevent colon cancer from coming back in 889 patients who had surgery and chemotherapy for high-risk stage II or stage III colon cancer. Participants were randomly assigned to either the exercise program plus…
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Should cancer patients get antibiotics for a dubious c. diff test? small trial seeks answers
Disease control CompletedThis study looked at whether giving the antibiotic vancomycin helps cancer patients who have diarrhea and a positive screening test for C. difficile but a negative toxin test. Only 9 patients were enrolled, far fewer than planned. Researchers measured changes in C. difficile leve…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Which surgery is safer for a burst colon? new study compares options
Disease control CompletedThis study compared two surgical methods for treating a burst section of the colon caused by diverticulitis, a condition that leads to severe abdominal infection. 102 adults with this infection were randomly assigned to either a traditional two-step surgery (Hartmann procedure) o…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control CompletedThis completed Phase 2b trial tested an oral tablet called JNJ-77242113 against placebo in 252 adults with moderate-to-severe ulcerative colitis. The goal was to see if the drug could reduce symptoms and inflammation better than a dummy pill. Researchers measured clinical respons…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Polyphenol power: could these plant compounds fight pollution harm?
Disease control CompletedThis completed trial tested whether a mix of 43 plant polyphenols can counteract health damage from environmental pollutants. 98 adults took either the polyphenol supplement or a placebo for a period. Researchers measured changes in gut health, inflammation, and blood markers to …
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Dietary change may curb recurrent c. diff in cancer patients
Disease control CompletedThis study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. di…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug shows promise for inflammatory bowel disease in Mid-Stage trial
Disease control CompletedThis phase 2b trial tested a new drug called TEV-48574 (duvakitug) in 290 adults with moderate to severe ulcerative colitis or Crohn's disease. The study aimed to see if the drug could help patients achieve clinical remission (for UC) or an endoscopic response (for CD) after 14 w…
Phase: PHASE2 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Gut bacteria capsules take on superbugs in antibiotic patients
Disease control CompletedThis study tested whether taking capsules containing healthy gut bacteria could help clear drug-resistant germs (including C. difficile) from the intestines of 42 hospitalized adults who needed at least 7 days of antibiotics. Participants received either the bacteria capsules or …
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New antibiotic CRS3123 takes on c. diff in early trial
Disease control CompletedThis phase 2 study tested an experimental antibiotic called CRS3123 against the standard treatment vancomycin for Clostridioides difficile infection (C. diff). 43 adults with a first episode or first recurrence of C. diff took either CRS3123 or vancomycin for 10 days. The main go…
Phase: PHASE2 • Sponsor: Crestone, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Poop pills? fecal transplants show promise for gut infections
Disease control CompletedThis study tested fecal microbiota transplant (FMT) in 24 adults with recurrent Clostridium difficile infection (C. diff) that didn't get better with standard antibiotics. FMT involves placing healthy donor stool into the patient's colon to restore good bacteria. The goal was to …
Phase: PHASE4 • Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Poop pills show promise for gut disease
Disease control CompletedThis study tested whether fecal transplants from healthy donors could help people with ulcerative colitis, a chronic condition causing inflammation in the colon. 85 participants received either donor or their own stool via tubes and enemas. The goal was to see if donor transplant…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study: does starting this pill sooner save colitis patients from surgery?
Disease control CompletedThis study looked back at medical records of 81 people with severe ulcerative colitis to see if starting upadacitinib early works better than using it after other treatments fail. Researchers checked how many avoided surgery and achieved remission within 12 weeks. The goal is to …
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a probiotic ease gut troubles in babies with food allergies?
Disease control CompletedThis study tested a probiotic called INF108F in 20 breastfed infants with a food allergy that causes blood in their stool. The goal was to see if the probiotic could improve the balance of gut bacteria and reduce symptoms like reflux and fussiness. While the treatment aims to con…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New oral drug shows promise for ulcerative colitis in early trial
Disease control CompletedThis study tested an experimental pill called MORF-057 in 39 adults with moderate to severe ulcerative colitis. The drug aims to reduce gut inflammation by blocking a specific protein. Researchers measured changes in colon tissue health and symptom scores after 12 weeks of treatm…
Phase: PHASE2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug cocktail shows promise for tough colon cancer
Disease control CompletedThis study tested a combination of two drugs, palbociclib and cetuximab, in 24 people with a specific type of advanced colon cancer that had spread. The goal was to see if the combo could shrink tumors or stop them from growing. Participants took palbociclib pills and received ce…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a High-Fiber diet soothe ulcerative colitis? new study tests UC-TREAT
Disease control CompletedThis study tested a 15-day diet called UC-TREAT, rich in high-fiber foods, fermented foods, and berries, in 36 adults—some healthy and some with quiescent (inactive) ulcerative colitis. Researchers measured changes in gut bacteria, digestive symptoms, and diet acceptability. The …
Phase: NA • Sponsor: University of Glasgow • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug combo shows promise against deadly gut infection
Disease control CompletedThis study tested whether adding the drug bezlotoxumab to standard treatment could prevent serious outcomes in people with a severe C. diff infection. Researchers used a special score to identify 44 high-risk patients. The goal was to see if the drug reduced organ failure, infect…
Phase: PHASE2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can pelvic floor exercises help pouch patients regain control?
Disease control CompletedThis study tested whether physiotherapist-led pelvic floor and bowel training could improve bowel function in people who had ileo-anal pouch surgery for ulcerative colitis or familial adenomatous polyposis. Fifty-three participants were randomly assigned to either the behavioural…
Phase: NA • Sponsor: St Vincent's Hospital Melbourne • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New combo attack on liver tumors shows promise for Tough-to-Treat cancer
Disease control CompletedThis phase 2 trial tested a three-part treatment for people with colorectal cancer that spread to the liver and stopped responding to standard treatments. The approach combines two minimally invasive procedures (TACE and HAIC) with the targeted drug regorafenib. The goal was to s…
Phase: PHASE2 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
CRISPR-Engineered immune cells take on stomach and colon cancers
Disease control CompletedThis trial tested a new approach for people with advanced gastrointestinal cancers that had stopped responding to standard treatments. Doctors removed immune cells from patients' tumors, used CRISPR gene editing to disable a gene called CISH, and then infused the modified cells b…
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Parasite protein injection aims to tame Crohn's Flare-Ups
Disease control CompletedThis phase 2 trial tested the safety of P28GST, a protein from a parasite, in 10 adults with moderate Crohn's disease. Participants received three injections over three months. The goal was to see if the protein could safely control inflammation, especially after intestinal surge…
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a prebiotic soothe ulcerative colitis?
Disease control CompletedThis study tested whether a prebiotic called 2'-fucosyllactose can help people with mild-to-moderate ulcerative colitis. 38 adults took the prebiotic or a placebo for four weeks, then switched. Researchers measured symptoms, gut bacteria, and inflammation markers. The goal was to…
Phase: NA • Sponsor: Royal Berkshire NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo shows promise for Hard-to-Treat colon cancer
Disease control CompletedThis early-phase study tested a combination of two drugs, regorafenib and nivolumab, in 52 people with advanced colorectal cancer that had stopped responding to other treatments. The goal was to find the safest dose and see if the combination could help control the cancer. The st…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis phase II trial tested a combination of three drugs—TAS-102, irinotecan, and bevacizumab—in 42 people with advanced colorectal cancer that had spread or couldn't be removed. The goal was to see if this mix could slow tumor growth better than standard treatments. Participants …
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Aspirin and diet may fight cancer return
Disease control CompletedThis study looked at whether taking daily aspirin and vitamin D, along with exercise and a low-fat diet, could help prevent colorectal cancer from returning in 16 patients who had no visible cancer but still had signs of cancer DNA in their blood. The goal was to see if these lif…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New antibody combo shows promise against Hard-to-Treat colorectal cancer
Disease control CompletedThis phase II trial tested two different drug combinations in 240 people with advanced HER2-positive colorectal cancer that had spread and could not be removed by surgery. One group received the antibodies trastuzumab and pertuzumab, while the other received cetuximab (an antibod…
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
App-Based monitoring shows promise for IBD patients
Disease control CompletedThis study tested a web-based telemonitoring system called TECCU for people with moderate-to-severe inflammatory bowel disease (Crohn's disease or ulcerative colitis). 290 participants in Spain were randomly assigned to use the app or receive usual care. The goal was to see if th…
Phase: NA • Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New cocktail shows promise against spread colon cancer
Disease control CompletedThis study tested a combination of the targeted drug cetuximab with a strong chemotherapy cocktail (FOLFIRINOX) as a first treatment for people whose colorectal cancer had spread and could not be removed by surgery. The goal was to see if this mix could shrink tumors better than …
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a sedative shield elderly lungs during cancer surgery?
Disease control CompletedThis study looked at whether the drug dexmedetomidine, given during laparoscopic surgery for rectal or sigmoid colon cancer, can protect the lungs of patients aged 60 and older. The trial included 64 participants and measured oxygen levels and other breathing indicators. The goal…
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New cocktail of drugs shows promise for tough colorectal cancer
Disease control CompletedThis phase 1 trial tested a combination of regorafenib (a targeted therapy) plus two immunotherapy drugs (nivolumab and ipilimumab) in 39 patients with advanced colorectal cancer that had spread and stopped responding to chemotherapy. The goal was to find the safest dose and chec…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common plant compound tame ulcerative colitis?
Disease control CompletedThis study tested whether rutin, a natural compound found in plants, can help people with ulcerative colitis. 60 adults took rutin tablets or a placebo for 30 days. The goal was to see if rutin reduces gut inflammation and improves symptoms like diarrhea and abdominal pain.
Phase: PHASE2 • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immune cells from cord blood aim to wipe out hidden colon cancer
Disease control CompletedThis early-phase study tested a combination therapy in 15 people with colon cancer who had completed standard treatment but still had tiny amounts of cancer DNA in their blood (called minimal residual disease). The treatment used specially activated immune cells from donated umbi…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
Colon polyp showdown: which removal method wins?
Disease control CompletedThis study compared two procedures for removing large, flat colon polyps (over 25 mm) in 360 adults. One method, ESD, removes the polyp in one piece but has higher risks and costs. The other, EMR, removes it in pieces but is safer and cheaper. The goal was to see which leads to f…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo targets stubborn colon cancer
Disease control CompletedThis study tested a combination of two drugs, sorafenib and bevacizumab, in 83 people with advanced colorectal cancer that had spread and was no longer responding to standard treatments. The goal was to see if this combination could stop or slow tumor growth. Participants receive…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Real-World study checks if tofacitinib tames ulcerative colitis
Disease control CompletedThis study followed 152 adults with moderate to severe ulcerative colitis who were prescribed tofacitinib by their doctors in France. Researchers tracked how many patients felt better after one and two years of treatment, using symptom scores and noting if they needed other medic…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New study confirms Upadacitinib's safety for inflammatory bowel disease in korean patients
Disease control CompletedThis completed study looked at how safe and effective upadacitinib (RINVOQ) is for Korean adults with moderate to severe ulcerative colitis or Crohn's disease. About 600 participants were followed for up to 52 weeks while taking the drug as prescribed by their doctor. The main go…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
IBD patients may ditch IV drips for simple shots
Disease control CompletedThis study tested switching 38 adults with inflammatory bowel disease (Crohn's or ulcerative colitis) from intravenous infliximab to a subcutaneous (under-the-skin) injection. Researchers measured drug levels, quality of life, and patient satisfaction over 24 weeks. The goal was …
Phase: NA • Sponsor: Zuyderland Medisch Centrum • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for kids with severe colitis: drug shows promise in small trial
Disease control CompletedThis study tested a drug called TA-650 in 21 children with moderate to severe ulcerative colitis, a condition causing inflammation and sores in the colon. The goal was to see if the drug could reduce disease activity and improve symptoms. Children received the drug by infusion at…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for ulcerative colitis: Long-Term safety of oral drug tested
Disease control CompletedThis study looked at the long-term safety and effectiveness of an oral medication called RPC1063 for people with moderate to severe ulcerative colitis. It included 877 adults who had already taken part in earlier RPC1063 trials. The goal was to see how well the drug controls the …
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Rinvoq shows promise for ulcerative colitis in Real-World japanese study
Disease control CompletedThis study looked at how safe and effective the drug Rinvoq is for adults with moderate to severe ulcerative colitis. About 300 people in Japan took Rinvoq as part of their normal care and were followed for up to 60 weeks. The main goal was to track serious infections and other s…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Simple drug may cut infection risk after major gut surgery
Disease control CompletedThis study tested whether tranexamic acid, a drug that helps blood clot, can lower the chance of infection after gastrointestinal surgery. Over 3,300 adults at higher risk for complications took part. The goal was to see if the drug reduces surgical site infections compared to a …
Phase: PHASE4 • Sponsor: Bayside Health • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Real-World study confirms kynteles safety for IBD patients
Disease control CompletedThis study monitored 688 people in South Korea with ulcerative colitis, Crohn's disease, or pouchitis who were treated with Kynteles (vedolizumab) as part of their normal care. The main goal was to track side effects, and researchers also looked at how many patients saw symptom i…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New pill shows promise for ulcerative colitis in early trial
Disease control CompletedThis study tested an experimental drug called ABBV-668 in 30 adults with moderate to severe ulcerative colitis, a condition that causes inflammation and bleeding in the colon. Participants took the drug twice daily for 16 weeks, and researchers checked for side effects and signs …
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Heated chemo combo tested in abdominal cancer surgery
Disease control CompletedThis study tested a treatment for peritoneal carcinosis, a cancer that has spread to the lining of the abdomen from the stomach, bowel, or appendix. The approach combined surgery to remove visible tumors with heated chemotherapy drugs (mitomycin C and irinotecan) pumped directly …
Phase: PHASE1, PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug shows promise for ulcerative colitis sufferers
Disease control CompletedThis study tested a new drug called PF-06480605 in 246 adults with moderate to severe ulcerative colitis. Participants received different doses of the drug or a placebo for 12 weeks, then everyone received the active drug for 40 more weeks. The goal was to see if the drug could h…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New surgical approach may improve outcomes for bowel disease patients
Disease control CompletedThis study tested whether adding a transanal (through the anus) approach to standard laparoscopic pelvic pouch surgery could improve outcomes for patients with ulcerative colitis or familial adenomatous polyposis. The transanal method may give surgeons better control and visibili…
Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study checks if VedAryo tames IBD Flare-Ups
Disease control CompletedThis study followed 150 people with inflammatory bowel disease (ulcerative colitis or Crohn's disease) who were given VedAryo (vedolizumab) to see if it helps control their condition and is safe. Participants received the drug by IV at the start, after 2 weeks, after 6 weeks, and…
Sponsor: AryoGen Pharmed Co. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Blood test guides smarter IBD treatment in landmark trial
Disease control CompletedThis study tested whether a blood test measuring proteins can help doctors choose the best treatment for people newly diagnosed with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. 300 patients were split into two groups: one where doctors had …
Phase: PHASE4 • Sponsor: Region Örebro County • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI and cap team up to spot hidden colon polyps
Disease control CompletedThis study tested whether using an artificial intelligence system (GI GENIUS) together with a special cap (ENDOCUFF VISION) on the colonoscope helps doctors find more precancerous polyps during colonoscopy than using either tool alone. About 481 adults undergoing screening or fol…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for ulcerative colitis sufferers: experimental drug shows promise
Disease control CompletedThis study tested an experimental drug called ABX464 in 355 adults with moderate to severe ulcerative colitis who had not responded well to other treatments. The goal was to see if the drug could reduce symptoms like diarrhea, bleeding, and colon inflammation. Participants receiv…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New capsule aims to revive old antibiotic for gut infection
Disease control CompletedThis study tests a new delayed-release metronidazole capsule designed to release the drug directly in the colon, where C. diff bacteria live. 18 healthy adults will receive a single dose of either the new capsule or the standard tablet to compare how much drug reaches the colon v…
Phase: PHASE1 • Sponsor: Gateway Pharmaceutical LLC • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Experimental vaccine trains immune system to fight multiple cancers
Disease control CompletedThis study tested a cancer vaccine called ETBX-011 in 43 people with advanced colorectal, lung, breast, or prostate cancers that produce a protein called CEA. The vaccine uses a modified virus to teach the immune system to attack cancer cells making CEA. The main goals were to ch…
Phase: PHASE1, PHASE2 • Sponsor: NantCell, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Vitamin d boosts chemo response in colorectal cancer patients?
Disease control CompletedThis study looked at whether taking vitamin D supplements can help people with stage II or III colorectal cancer who are receiving chemotherapy. The researchers measured markers of cell death and inflammation in 44 patients before and after 6 months of vitamin D. The goal was to …
Phase: PHASE4 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New chemo cocktail tested to prevent colon cancer return
Disease control CompletedThis study tested whether a stronger chemotherapy combination (mFOLFIRINOX) works better than the standard one (mFOLFOX) for people with high-risk stage III colon cancer after surgery. About 792 patients took part across multiple countries. The goal was to see if the stronger com…
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could an old antibiotic tame ulcerative colitis?
Disease control CompletedThis study tested whether adding the antibiotic minocycline to standard mesalamine treatment helps control mild-to-moderate ulcerative colitis. 46 adults took part. Researchers measured disease activity using a symptom score. The trial is complete, but results are not yet publish…
Phase: PHASE2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a common heart drug ease ulcerative colitis?
Disease control CompletedThis study tested whether adding atorvastatin (a cholesterol-lowering drug) to standard mesalamine treatment improves quality of life and reduces inflammation in adults with ulcerative colitis. 54 participants completed the trial. The goal was to see if the drug's anti-inflammato…
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for ulcerative colitis: drug shows promise in early trial
Disease control CompletedThis study tested a new drug called IBI112 in 150 people with moderate to severe ulcerative colitis, a condition that causes inflammation and sores in the colon. The goal was to see if IBI112 could help patients achieve remission (no symptoms) after 12 weeks of treatment. Partici…
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Less antibiotics, same safety: new study on appendicitis recovery
Disease control CompletedThis study looked at whether giving fewer antibiotics after appendix removal is safe and effective. 268 adults who had surgery for simple or complicated appendicitis took part. The goal was to see if a short course of antibiotics could reduce side effects without increasing compl…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
App helps young cancer survivors shed pounds
Disease control CompletedThis study tested a smartphone app to help young adult cancer survivors (ages 18-39) lose weight. The app tracked diet and activity as part of a behavioral weight loss program. The goal was to see if this approach was practical and well-liked by participants. The study involved 6…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill aims to tame ulcerative colitis Flare-Ups
Disease control CompletedThis study tested a once-daily pill called ABX464 (obefazimod) in 639 people with moderate-to-severe ulcerative colitis who had not responded well to other treatments. The goal was to see if the drug could help bring about remission and improve bowel inflammation within 8 weeks. …
Phase: PHASE3 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill shows promise for ulcerative colitis in major trial
Disease control CompletedThis study tested a new daily pill, ABX464, for people with moderate to severe ulcerative colitis who did not get better with other treatments. About 636 adults and teens took either 25 mg, 50 mg, or a placebo for 8 weeks. The main goal was to see if the drug could help achieve r…
Phase: PHASE3 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug shows promise for Long-Term ulcerative colitis control
Disease control CompletedThis study looked at the long-term safety of a drug called spesolimab in adults with moderate to severe ulcerative colitis who had already finished earlier trials. Researchers tracked side effects and checked if patients achieved remission over about 6.5 years. The goal was to se…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New biologic shows promise for Tough-to-Treat ulcerative colitis
Disease control CompletedThis study tested whether mirikizumab, a biologic drug, can improve symptoms and gut healing in 100 people with moderate-to-severe ulcerative colitis who had a specific type of inflammation seen on biopsy. Participants received either mirikizumab or vedolizumab, and doctors track…
Phase: PHASE4 • Sponsor: Showa Inan General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New daily pill could tame ulcerative colitis in japanese patients
Disease control CompletedThis study tested two doses of a daily pill called ozanimod in 198 Japanese adults with moderate to severe ulcerative colitis. The goal was to see if it could reduce symptoms and inflammation better than a placebo. The trial also checked long-term safety. Ozanimod works by calmin…
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for tough ulcerative colitis cases: spesolimab trial shows promise
Disease control CompletedThis study tested a new drug called spesolimab in 98 adults with moderate-to-severe ulcerative colitis who did not get better with other biologic treatments. The goal was to see if the drug could safely reduce symptoms and help the colon heal. The trial was completed and looked a…
Phase: PHASE2, PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug combo shows promise for stubborn ulcerative colitis
Disease control CompletedThis phase 2 study tested whether adding spesolimab to standard TNF inhibitor therapy could help heal the gut lining in people with mild-to-moderate ulcerative colitis. Twenty-two adults who still had active disease despite TNF inhibitor treatment received spesolimab or a placebo…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug shows promise for ulcerative colitis in early trial
Disease control CompletedThis phase 2 trial tested a drug called spesolimab in 8 adults with moderate to severe ulcerative colitis. The main goal was to understand how the drug works in the body, while also checking for safety and any signs of improvement. Participants received the drug for 12 weeks, and…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Humira shows promise for Long-Term control of Kids' colitis
Disease control CompletedThis study looked at the long-term safety and effectiveness of adalimumab (Humira) in 59 children with ulcerative colitis who had already completed a previous trial. The children received injections every other week or weekly. Researchers tracked side effects and how well the dru…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Smart dosing keeps chemo on track for GI cancer patients
Disease control CompletedThis study tested a doctor-designed dose adjustment algorithm to prevent unplanned delays in FOLFOX chemotherapy for people with cancers of the colon, stomach, esophagus, and other digestive organs. 52 adults participated, and the goal was to see if the algorithm could keep treat…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New surgery showdown: which bowel procedure keeps Crohn's at bay?
Disease control CompletedThis study looked at 73 adults with Crohn's disease who needed surgery to remove a diseased part of the bowel. Researchers compared two different ways to reconnect the healthy ends: one that removes the fatty tissue around the bowel (mesentery) and one that keeps it (Kono-S). The…
Phase: NA • Sponsor: Azienda Ospedaliera Ordine Mauriziano di Torino • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Blood tests could fine-tune IBD treatment, saving money and improving lives
Disease control CompletedThis study looked at whether regularly measuring levels of anti-TNF drugs and antibodies in the blood can help doctors better manage inflammatory bowel disease (Crohn's and ulcerative colitis). 260 patients were split into two groups: one where doctors used these test results to …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug cocktail shows promise in rare colorectal cancer
Disease control CompletedThis study tested a combination of three drugs (encorafenib, binimetinib, and cetuximab) given before surgery to people with a specific type of colorectal cancer that has a BRAF V600E mutation. Only 2 patients took part. The goal was to see how much the tumor shrank and to check …
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Gut bacteria boost: can probiotics help ulcerative colitis patients stay in remission?
Disease control CompletedThis study looked at whether adding probiotics (Bacillus Clausii) to standard mesalamine treatment helps people with ulcerative colitis stay in remission. 70 adults in remission were split into groups: mesalamine alone, probiotics alone, or both. Researchers tracked disease activ…
Sponsor: Tanta University • Aim: Disease control
Last updated Jun 26, 2026 18:29 UTC
-
New combo tackles Tough-to-Treat colorectal cancer
Disease control CompletedThis early-phase trial tested a combination of two drugs—copanlisib and nivolumab—in 48 adults with advanced solid tumors, specifically a type of colorectal cancer called MSS that usually doesn't respond to immunotherapy alone. The goal was to see if the combination could shrink …
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 26, 2026 18:01 UTC
-
New study tracks Real-World use of entyvio in over 1,100 ulcerative colitis patients
Disease control CompletedThis completed study looked at the long-term safety and effectiveness of vedolizumab (Entyvio) in over 1,100 people with moderate to severe ulcerative colitis who had not responded well to other treatments. Researchers tracked side effects and how well the drug controlled disease…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 26, 2026 15:57 UTC
-
New pill could ease ulcerative colitis symptoms
Disease control CompletedThis study tested an oral drug called amiselimod (MT-1303) in 322 adults with mild to moderate ulcerative colitis. Participants received either a low dose, high dose, or placebo for 12 weeks, with an optional 36-week open-label period. The goal was to see if the drug could reduce…
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:08 UTC
-
Experimental Vaccine-Like therapy targets Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested an experimental immunotherapy called ELI-002 in 25 people with KRAS-mutated pancreatic, colorectal, lung, ovarian, or bile duct cancers who had signs of remaining disease after standard treatment. The therapy aims to train the immune system to attack…
Phase: PHASE1 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 13:30 UTC
-
Can seniors handle colon cancer chemo? new study aims to find out
Disease control CompletedThis study looked at how well patients aged 75 and older tolerate chemotherapy after surgery for stage III colon cancer. Researchers measured changes in daily living activities and used geriatric assessments and gene tests to predict outcomes. The goal is to better identify which…
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:30 UTC
-
Can a team approach help IBD patients with anxiety and depression?
Disease control CompletedThis study tested two team-based care models for 657 adults with inflammatory bowel disease (Crohn's or ulcerative colitis) who also had mild to severe behavioral health symptoms. One model used in-person visits with a team including a gastroenterologist, nurse, nutritionist, and…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC
-
AI eye on your colon: can software spot polyps better?
Diagnosis CompletedThis study tests whether a software called ColoMaia II can help doctors find abnormal growths (polyps) in the colon during a routine colonoscopy. About 600 adults aged 40 to 80 having a screening or diagnostic colonoscopy will be randomly assigned to have the procedure with or wi…
Phase: NA • Sponsor: MAIA Labs s.r.o. • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may spot appendicitis faster, study finds
Diagnosis CompletedThis study looked at whether measuring a protein called calprotectin in the blood can help diagnose acute appendicitis. Researchers compared 74 patients with abdominal pain, some with confirmed appendicitis and others with non-specific pain. They measured calprotectin levels and …
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
AI-Powered Low-Radiation CT scans could transform emergency diagnosis
Diagnosis CompletedThis study tested whether a low-dose CT scan, enhanced with deep learning image reconstruction, can diagnose acute abdominal conditions as accurately as a standard CT scan. 246 adults with abdominal pain received both scans, and the low-dose version used less than 30% of the usua…
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Which test spots colon leaks best? new study compares CT and endoscopy
Diagnosis CompletedThis study looked at 416 people who had left-sided colon surgery. A few days after surgery, each person got both a CT scan and an endoscopy to check for leaks where the colon was reconnected. The goal was to see which test is more accurate at finding these leaks. Results help doc…
Sponsor: Spital Limmattal Schlieren • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New test spots stray cancer cells that standard methods miss
Diagnosis CompletedThis study looked at a new test called OSNA to find free cancer cells in the belly fluid of 108 people with stomach or colon cancer who had no visible spread. The goal was to see if OSNA could detect cancer cells better than the usual lab method. If successful, this could help do…
Sponsor: University of Campania Luigi Vanvitelli • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Which test is best for colon cancer screening in High-Risk families?
Diagnosis CompletedThis study looked at three screening methods—colonoscopy, colon capsule endoscopy, and a fecal immunochemical test (FIT)—to detect colorectal cancer or advanced growths in people aged 45 and older who have a first-degree relative with colorectal cancer. The goal was to see if the…
Sponsor: Hôpital Edouard Herriot • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
AI boosts polyp detection in colon cancer screening Follow-Up
Diagnosis CompletedThis study tested whether an AI tool (GI Genius) helps doctors find more polyps during colonoscopy in people aged 50-74 who had a previous polyp. Over 1,100 participants were randomly assigned to either AI-assisted or standard colonoscopy. The main goal was to see if AI increases…
Phase: NA • Sponsor: Fondazione Poliambulanza Istituto Ospedaliero • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple blood test boost colon cancer screening in appalachia?
Diagnosis CompletedThis study looked at whether offering a blood test for colorectal cancer screening would be accepted by average-risk patients in Appalachian outpatient clinics. Over 200 participants were given the option of a standard screening method or a blood-based test called Shield. The goa…
Phase: NA • Sponsor: Ballad Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Blood test ratios may offer cheaper way to track colitis
Diagnosis CompletedThis study tested whether simple blood test ratios, like CRP-to-albumin, can help monitor disease activity in people with ulcerative colitis. Researchers compared these blood markers to standard colonoscopy and symptom scores in 80 patients. The goal was to find a less invasive, …
Sponsor: Benha University • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Simple blood test could spot Crohn's and colitis earlier
Diagnosis CompletedThis study looked at four substances in the blood (Osteoprotegerin, sRANKL, NFkB, and TFF3) to see if they could help diagnose inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. Researchers measured these markers in 70 newly diagnosed patient…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may spot colon cancer early, study shows
Diagnosis CompletedThis study tested a new blood test designed to find colorectal cancer early in people at average risk. Nearly 49,000 adults aged 45-85 gave a blood sample before their routine colonoscopy. The goal was to see how well the blood test could detect cancer and advanced growths compar…
Sponsor: Freenome Holdings Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Blood test could boost colorectal cancer screening rates
Diagnosis CompletedThis study looked at whether offering a simple blood test (GuardantSHIELD) could help more people complete colorectal cancer screening compared to usual care. Over 2,000 adults aged 45-75 who were overdue for screening took part. The main goal was to see if more people got screen…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New scoring tool aims to speed up appendicitis surgery decisions
Diagnosis CompletedThis study looked at whether the Appendistat Score (APS) can accurately identify patients with complicated appendicitis who need urgent surgery. Researchers reviewed records of 592 patients who had their appendix removed. They compared the APS score to the final lab results to se…
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
New colonoscope attachment aims to spot hidden polyps
Diagnosis CompletedThis study tested whether a device called Endocuff Vision, which attaches to the tip of a colonoscope and has soft projections to flatten folds in the colon, can help doctors find more sessile serrated adenomas—a type of precancerous polyp. Over 400 adults undergoing routine scre…
Phase: NA • Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Colonoscopy vs. stool test: which screens better for colon cancer?
Prevention CompletedThis phase 3 trial compared colonoscopy with annual fecal occult blood tests for colorectal cancer screening in nearly 5,000 healthy adults aged 50-69. The goal was to see which method finds more early tumors and has a better balance of benefits and harms. Participants were rando…
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Real-world data shows REBYOTA™ may stop c. diff from coming back
Prevention CompletedThis observational study followed 145 adults who received REBYOTA™ to prevent another Clostridioides difficile infection (CDI) after completing antibiotics. Researchers collected information from medical records over 6 months to see how many people stayed infection-free. The goal…
Sponsor: Ferring Pharmaceuticals • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Could a simple antibiotic taper stop c. diff relapse?
Prevention CompletedThis study tested whether extending standard vancomycin treatment for C. diff infection with a 2-week taper (lowering the dose gradually) reduces the chance of the infection returning. 263 adults who had a first episode or first recurrence of C. diff were randomly assigned to rec…
Phase: PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Stool transplant plus antibody drug shows promise against recurrent c. diff in IBD patients
Prevention CompletedThis study tested whether combining a fecal microbiota transplant (FMT) with the drug bezlotoxumab could prevent repeat Clostridium difficile infections in people with inflammatory bowel disease (IBD). Sixty-one adults with at least two prior C. diff infections were randomly assi…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Less antibiotics after appendix surgery may cut side effects
Symptom relief CompletedThis study looked at whether giving fewer antibiotics after appendicitis surgery could lower the risk of antibiotic side effects without compromising patient safety. Over 650 adults who had surgery for simple or complicated appendicitis took part. The goal was to find the right b…
Phase: NA • Sponsor: Denver Health and Hospital Authority • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New recovery plan may get kids home faster after bowel surgery
Symptom relief CompletedThis study tested a 21-step enhanced recovery protocol for children aged 10-18 undergoing elective gastrointestinal surgery. The protocol included things like shorter fasting times, early eating and moving, and less use of opioids. The goal was to see if it could shorten hospital…
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Could a simple drug combo cut morphine use after colon surgery?
Symptom relief CompletedThis study looked at whether adding the drug nefopam to standard pain relief (morphine and paracetamol) can reduce the amount of morphine needed after major colon surgery. 80 adults having planned surgery for colon cancer or diverticulosis took part. The main goal was to measure …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Warm gas during keyhole surgery may cut pain and opioid use
Symptom relief CompletedThis study tested whether using warm, humidified carbon dioxide gas during low-pressure laparoscopic colorectal surgery reduces pain 24 hours after the procedure. 148 adults having surgery for colon or rectal tumors (benign or malignant) took part. One group received warm, moist …
Phase: NA • Sponsor: Bordeaux Colorectal Institute Academy • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Talking it out: could CBT ease anxiety and depression in IBD patients?
Symptom relief CompletedThis study tests whether cognitive behavioral therapy (CBT) can reduce anxiety and depression in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). Participants receive either psychologist-led or self-administered CBT over 8 weeks. The goal is to see …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Beauty treatments ease cancer pain and anxiety, study finds
Symptom relief CompletedThis study tested whether professional socio-aesthetics (specialized beauty and well-being care) can improve quality of life, reduce pain, and ease anxiety in adults undergoing chemotherapy for lung, breast, colon, or prostate cancer. 400 participants were randomly assigned to re…
Phase: NA • Sponsor: Centre Hospitalier de Valence • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Numbing injection may cut appendicitis pain before emergency surgery
Symptom relief CompletedThis study tested whether a numbing injection into the abdominal wall muscles (called a TAP block) can reduce pain for people with acute appendicitis waiting for emergency surgery. 105 adults in the emergency department received the block, and researchers measured how much pain m…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New digital tool aims to boost Pre-Surgery fitness in seniors with colon cancer
Symptom relief CompletedThis study tested a web app called PrehabPal designed to help frail adults aged 65 and older prepare for colon cancer surgery. The app creates a personalized prehabilitation program and offers coaching. Researchers compared it to standard written instructions in 132 participants …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Can an online wellness program ease anxiety in chronic disease?
Symptom relief CompletedThis study tested a 12-week online mind-body program for adults with chronic conditions like heart failure, cancer, and liver disease. The program included mindful movement, meditation, breathwork, and coping skills. Researchers measured changes in anxiety, depression, fatigue, a…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Which pain block works best for kids after appendix removal?
Symptom relief CompletedThis study compared two types of nerve blocks—erector spinae plane (ESP) and quadratus lumborum (QL)—to see which provides better pain relief after appendix surgery in children aged 3-13. Sixty children received one of the blocks along with general anesthesia. Researchers measure…
Phase: NA • Sponsor: Zeycan Kahya • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Ice packs may cut opioid use after Kids' appendix surgery
Symptom relief CompletedThis study tested whether using a cold therapy device on the belly after appendix removal helps control pain in children ages 7 and older. Half the kids got the cold pack plus usual care, the other half got usual care alone. Researchers measured pain scores, morphine use, and hos…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Nurse phone calls may ease chemo side effects and anxiety
Symptom relief CompletedThis study tested whether two nurse phone calls during the first three cycles of chemotherapy could improve the emotional state and quality of life of patients with breast, colon, or rectal cancer. 274 patients were randomly assigned to receive either standard care or standard ca…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New online program aims to ease cancer treatment side effects
Symptom relief CompletedThis study tested a web-based support program for people with colorectal cancer undergoing treatment. The program provided information and tips on physical, emotional, and daily-life challenges. Researchers measured whether it helped reduce symptoms and improve quality of life co…
Phase: NA • Sponsor: Ilknur Yazicioglu • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Could a probiotic soothe PTSD? new study tests Gut-Brain link in veterans
Symptom relief CompletedThis study tested whether a probiotic called Lactobacillus rhamnosus GG can reduce inflammation and PTSD symptoms in veterans. Researchers enrolled 383 veterans with PTSD and gut issues, giving them either the probiotic or a placebo. The goal was to see if calming inflammation in…
Phase: PHASE2 • Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Smaller tools, less pain? new study tests 'low-impact' appendix surgery
Symptom relief CompletedThis study tested a newer, gentler type of keyhole surgery for removing the appendix. It uses lower gas pressure and smaller instruments than standard laparoscopy. Fifty adults with uncomplicated appendicitis took part, and the researchers measured their pain, recovery time, and …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New pill could ease carcinoid syndrome Flare-Ups
Symptom relief CompletedThis Phase 2 trial tested paltusotine, an oral drug, in 36 adults with carcinoid syndrome. The study looked at safety and how the body processes the drug at different doses. Participants were randomly assigned to 40 mg or 80 mg daily, with dose adjustments allowed. The goal is to…
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New study examines pain and adherence in patients switching to concentrated adalimumab
Symptom relief CompletedThis study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration form of adalimumab (AVT-02). Researchers measured injection site pain and how well patients stuck with their treatment over 180 days…
Sponsor: Jamp Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Which pill do patients prefer? study compares two chemo options for colorectal cancer
Symptom relief CompletedThis study looked at two oral chemotherapy drugs, Xeloda and UFT with folinic acid, in 89 people with advanced or metastatic colorectal cancer. The main goal was to see which treatment patients preferred after trying both. The study also checked how safe each drug was. Results he…
Phase: PHASE3 • Sponsor: Centre Oscar Lambret • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Digital coaching eases cancer treatment struggles
Symptom relief CompletedThis study tested an online educational program for cancer patients receiving chemotherapy. The program included video sessions, peer discussions, and digital materials to help with symptom management and emotional coping. Researchers compared 212 patients who used the program to…
Phase: NA • Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a bile acid pill ease ulcerative colitis?
Symptom relief CompletedThis early-phase study tested whether TUDCA, a bile acid supplement, is safe and can reduce stress in gut cells of people with active ulcerative colitis. Fourteen adults took TUDCA for 6 weeks while researchers measured changes in cell stress markers from colon biopsies. The goal…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a plant-based supplement calm chemo-related diarrhea?
Symptom relief CompletedThis phase II trial tested a concentrated plant dietary supplement (made from foods like taro, rice, and carrots) in 30 people with gastrointestinal cancers who had diarrhea from chemotherapy. Participants received the supplement alongside standard anti-diarrheal treatment. The g…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New rehab program aims to ease life after colorectal cancer
Symptom relief CompletedThis study tested a personalized rehabilitation program for 150 adults who finished treatment for colorectal cancer. The program connects patients with specialists like physiotherapists, dietitians, and psychologists based on their individual needs. The goal was to improve qualit…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Nerve blocks may offer better pain relief for appendicitis patients in the ER
Symptom relief CompletedThis study compared two types of nerve blocks (TAP and ESPB) to standard pain medication (tramadol) for people with acute appendicitis in the emergency department. The goal was to see if these blocks could reduce pain before surgery and lower the need for opioids. The trial inclu…
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Gentler gas pressure may ease Kids' pain after appendix surgery
Symptom relief CompletedThis study looked at 250 children having laparoscopic surgery for appendicitis. It compared using low versus medium gas pressure in the belly during the operation to see if it affects pain the next day. The goal is to find ways to make children more comfortable after surgery.
Phase: NA • Sponsor: University Children's Hospital, Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Which nerve block eases Post-Surgery pain best?
Symptom relief CompletedThis study compared two types of nerve blocks (erector spinae plane block vs. transversus abdominis plane block) for pain relief after laparoscopic appendix removal. 72 adults aged 18-50 participated. The goal was to see which block provides better pain control and fewer complica…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Audio hypnotherapy could ease Kids' tummy troubles without meds
Symptom relief CompletedThis study tested if listening to hypnotherapy audio files can help children and teens with stomach pain and bowel problems linked to stress. 32 participants used the audio treatment at home. The goal was to see if this approach is practical and effective, potentially offering a …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Iron pill shows promise for anemia after colon cancer surgery
Symptom relief CompletedThis study tested whether an oral iron pill (ferric maltol) can improve anemia in 40 adults after colorectal cancer surgery, compared to standard care. The main goal was to see if a larger study is possible, while also checking blood iron levels. The approach is simple and aims t…
Phase: PHASE3 • Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Which pain block works best for colon surgery?
Symptom relief CompletedThis study compared two ways to manage pain during and after colorectal surgery: a TAP block (an injection into the abdominal wall) versus epidural anesthesia (an injection near the spine). About 200 adults having elective colon or rectal surgery for cancer or diverticulitis took…
Phase: NA • Sponsor: Trinity Health Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Broccoli sprouts: the surprising new hope for gut health?
Symptom relief CompletedThis study tested whether eating steamed broccoli sprouts daily for 28 days could increase anti-inflammatory compounds in the blood and stool of people with mild ulcerative colitis. 23 participants took either 1 or 3 servings of sprouts per day. The goal was to see if this diet i…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can acupuncture and ice chips beat chemo nerve damage?
Symptom relief CompletedThis phase 2 trial looked at whether adding acupuncture and acupressure to oral cryotherapy (sucking on ice chips) can reduce nerve pain caused by oxaliplatin chemotherapy in people with gastrointestinal cancers. 78 patients were split into two groups: one got cryotherapy alone, …
Phase: PHASE2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Texting your way to better health: study tests SMS diet coach for cancer survivors
Symptom relief CompletedThis study tested whether sending personalized text messages could help colorectal cancer survivors eat more whole grains and less refined grains. Forty-six survivors who had finished active treatment received text messages and nutrition materials. The main goal was to see if peo…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Gluten-Free diet tested for ulcerative colitis relief
Symptom relief CompletedThis study tested whether eating gluten-free for one week reduces gut symptoms and fatigue in people with ulcerative colitis. Fifteen participants followed both a high-gluten and a gluten-free diet in random order, with symptom questionnaires and samples collected. The goal is to…
Phase: NA • Sponsor: University of Southern Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New self-management program shows promise for IBD symptom relief
Symptom relief CompletedThis study tested a comprehensive self-management program for people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. The program included eight sessions covering topics like symptom tracking, relaxation, diet, and pain management. Research…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Can an app or a book ease IBD disability? large trial tests free Self-Help options
Symptom relief CompletedThis completed trial tested whether four free self-help resources—a symptom-tracking app, a cognitive behavioral therapy workbook, a helpline, and a peer mentor—can reduce disability in people with moderate-to-severe Crohn's disease or ulcerative colitis. Over 800 adults particip…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Music therapy before surgery eases nerves, study finds
Symptom relief CompletedThis study looked at whether listening to music for a week before colon cancer surgery can lower anxiety. 116 adults scheduled for surgery were asked to listen to music three times a day. Their anxiety levels were compared to a group that did not have a music routine. The goal is…
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New anesthesia drug may help kids wake up faster after surgery
Symptom relief CompletedThis study tested a new anesthesia drug called ciprofol in 86 children having laparoscopic surgery (like hernia repair or appendix removal). The goal was to see if it works as well as standard anesthesia for helping kids wake up and recover. Researchers measured how fast children…
Phase: NA • Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Exercise program shows promise for cancer Patients' Well-Being
Symptom relief CompletedThis study tested whether a 6-week supervised exercise program could improve quality of life and reduce fatigue in 78 breast and colon cancer patients. Participants were randomly assigned to either the exercise program or usual care, and were followed for one year. The main goal …
Phase: NA • Sponsor: Universidad Complutense de Madrid • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Exercise program aims to boost bone health in kids with IBD
Symptom relief CompletedThis study looked at whether a tailored physical activity program could improve bone density in 15 children and teens with inflammatory bowel disease (IBD). Kids with IBD often have weaker bones due to inflammation, medication, and lower activity levels. The program focused on mo…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can a smartphone app soothe Children's tummy troubles?
Symptom relief CompletedThis pilot study tested whether a guided imagery therapy mobile app could help children aged 7 to 12 with chronic abdominal pain. Four children listened to 10-15 minute recorded sessions five days a week for eight weeks. The study compared immediate app use to a delayed start gro…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a special liquid diet soothe IBD in rare immune disease?
Symptom relief CompletedThis study tested whether a liquid diet called Neocate Splash could change gut bacteria and ease stomach symptoms in people with chronic granulomatous disease (CGD) and inflammatory bowel disease (IBD). Three participants followed the diet for up to 4 weeks, with hospital stays a…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New diet rivals low FODMAP for gut relief
Symptom relief CompletedThis study tested a new diet called 5Ad against the well-known low FODMAP diet in 52 adults with ongoing stomach issues like bloating, pain, and irregular bowel movements. Each person tried both diets for a week, with a break in between. The goal was to see if the 5Ad diet works …
Phase: NA • Sponsor: University of Suffolk • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can a nasal oxygen device prevent low oxygen during endoscopy in sleep apnea patients?
Symptom relief CompletedThis study tested whether a high-flow nasal cannula (HFNC) can reduce the risk of low oxygen levels during sedated gastrointestinal endoscopy in 80 adults with high-risk obstructive sleep apnea. Participants had a STOP-Bang score of 5 or higher and were undergoing gastroscopy, co…
Phase: NA • Sponsor: Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can AI and VR ease anxiety in IBD patients? small study explores digital wellness
Symptom relief CompletedThis small study tested whether an AI-powered virtual reality app could safely provide mental health support to 22 adults with inflammatory bowel disease (IBD) who also had mild anxiety or depression. The goal was to see if the digital session was practical and acceptable, not to…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Talking therapy shows promise for brain cancer distress
Symptom relief CompletedThis study tested a therapy called Managing Cancer and Living Meaningfully (CALM) to see if it helps people with brain cancer feel less distressed. 60 adults with brain tumors or brain metastases who had high depression or death anxiety took part. The study measured how many peop…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New recovery recipe gets kids home sooner after appendix surgery
Symptom relief CompletedThis study tested a set of care steps called Enhanced Recovery After Surgery (ERAS) in 82 children who had their appendix removed. The steps included teaching families what to expect, avoiding tubes, and helping kids eat and move early after surgery. The goal was to see if this p…
Phase: NA • Sponsor: Karadeniz Technical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New pill for ulcerative colitis passes first safety check in healthy volunteers
Symptom relief CompletedThis early-stage trial tested whether an oral biologic drug called MB-001 is safe in 48 healthy adults. Participants received either a single dose or five daily doses of the drug or a placebo. The main goal was to check for side effects and see how the body processes the drug. Th…
Phase: PHASE1 • Sponsor: Mage Biologics • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can you go home the same day after appendix surgery? this study says maybe.
Symptom relief CompletedThis study looked at whether people with simple appendicitis can safely go home within 12 hours after surgery instead of staying overnight. Researchers followed 120 adults who had their appendix removed and checked if they were discharged quickly. The goal was to see if same-day …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New combo pill targets tummy troubles: pain and gas relief in one
Symptom relief CompletedThis study tested a fixed-dose combination of Mebeverine (a muscle relaxant) and Simethicone (a gas reducer) against each drug alone in 465 adults with functional bowel disorders causing abdominal pain and bloating. The goal was to see if the combo pill better reduces pain and bl…
Phase: PHASE3 • Sponsor: Abbott • Aim: Symptom relief
Last updated Jun 26, 2026 17:55 UTC
-
New pain relief method may rival epidurals after colon surgery
Symptom relief CompletedThis study compared two standard pain relief methods after colon or rectal surgery: a preperitoneal catheter that delivers local anesthetic near the surgical site, and an epidural catheter placed before surgery. Researchers measured pain scores and how much extra pain medication …
Phase: NA • Sponsor: Trinity Health Michigan • Aim: Symptom relief
Last updated Jun 26, 2026 17:15 UTC
-
Virtual reality goggles may calm chemotherapy patients
Symptom relief CompletedThis study tested whether using augmented virtual reality (AVR) during chemotherapy can help reduce pain, stress, and anxiety while boosting self-confidence. 150 adult cancer patients in the West Bank were split into two groups: one received standard care, and the other used AVR …
Phase: NA • Sponsor: Arab American University (Palestine) • Aim: Symptom relief
Last updated Jun 26, 2026 17:13 UTC
-
Fasting diet shows promise for depression in bowel disease
Symptom relief CompletedThis study tested whether a low-calorie, plant-based diet that mimics fasting could reduce depressive symptoms in people with inflammatory bowel disease (IBD). 42 adults with mild-to-moderate depression and IBD followed either the fasting-mimicking diet or a calorie-sufficient pl…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 26, 2026 16:34 UTC
-
Fiber pills may ease radiation side effects for pelvic cancer patients
Symptom relief CompletedThis completed phase 3 trial tested whether taking psyllium husk fiber capsules during pelvic radiation therapy could reduce gut inflammation and urgency symptoms. 354 adults with pelvic cancers (like rectal, prostate, or gynecological) took either fiber or placebo capsules daily…
Phase: PHASE3 • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 15:22 UTC
-
Lavender or pressure points: Drug-Free pain relief for kids after surgery?
Symptom relief CompletedThis study tested whether aromatherapy (breathing lavender oil) or acupressure (gentle thumb pressure on specific points) could reduce pain and improve sleep in 100 children aged 6-12 after abdominal surgeries like appendix or hernia repair. The goal was to find simple, non-drug …
Phase: NA • Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 26, 2026 14:18 UTC
-
Family talk could be key to preventing disease in Mexican-American communities
Knowledge-focused CompletedThis study examined how Mexican-American families discuss their risk for diabetes, heart disease, breast cancer, and colon cancer. Researchers interviewed 498 adults from Mexican-American households in Houston to understand how culture and family history influence health communic…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a simple activity tracker help cancer survivors move more?
Knowledge-focused CompletedThis study looked at whether using a physical activity screener, along with exercise coaching and self-monitoring, could help breast and colon cancer survivors become more active and spend less time sitting. Twenty survivors who had finished their main cancer treatment at least t…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists investigate gut-healing protein in Crohn's and colitis
Knowledge-focused CompletedThis study looked at how a protein called IL-22 binding protein (IL-22BP) affects gut healing in people with Crohn's disease or ulcerative colitis. Researchers compared samples from 52 patients and healthy volunteers to understand how IL-22BP is regulated during disease flares. T…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Appendicitis dilemma: survey reveals patient regret over treatment choice
Knowledge-focused CompletedThis completed study surveyed over 2,500 appendicitis patients to understand their satisfaction and regret after choosing either surgery or antibiotics. Researchers aim to use this information to design decision-support tools that help future patients make choices aligned with th…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Fit gut: study links exercise to healthier microbiome
Knowledge-focused CompletedThis study looks at how being physically fit changes the bacteria in your gut. Researchers will compare the gut microbes of 30 healthy men, from inactive to elite athletes, by testing their exercise capacity and analyzing stool samples. The goal is to find connections between fit…
Sponsor: University of Rennes 2 • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Gut bacteria may hold key to treating severe colitis
Knowledge-focused CompletedThis study investigates whether gut microorganisms and their byproducts play a role in triggering severe flare-ups of ulcerative colitis. Researchers will compare patients hospitalized with severe colitis to those with milder symptoms, analyzing stool and blood samples over three…
Phase: EARLY_PHASE1 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can fiber be gentle? study tests tolerable doses for sensitive guts
Knowledge-focused CompletedThis study looked at how well people with self-reported fiber sensitivity tolerate different doses of soluble fiber. 141 adults took fiber or a placebo for 7 days, and researchers measured digestive symptoms and dropout rates. The goal was to find a dose that causes minimal disco…
Phase: NA • Sponsor: Danone Global Research & Innovation Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists create detailed map of appendix cells
Knowledge-focused CompletedThis study aimed to create a detailed map of the cells in the human appendix and understand their genetic activity. Researchers analyzed appendix tissue from 5 patients undergoing colon cancer surgery. The goal was to learn more about the appendix's role in the immune system and …
Sponsor: Bispebjerg Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists create detailed map of colon cells to unlock disease secrets
Knowledge-focused CompletedThis completed study took small tissue samples from the colons of 40 people during routine colonoscopies. Using advanced genetic techniques, researchers created a detailed map of the different cell types and their gene activity. The goal is to better understand how colon diseases…
Sponsor: Bispebjerg Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Magnetic zaps to the spine: a new way to tame bowel troubles?
Knowledge-focused CompletedThis study looked at whether magnetic stimulation of nerves in the lower back can change how the colon moves. It included 30 people: healthy volunteers, and patients with constipation or fecal incontinence. The goal was to understand the effect, not to treat the condition.
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Massive study reveals hidden dangers of common steroid treatments
Knowledge-focused CompletedThis completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking r…
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Smart scans and DNA tests could revolutionize liver cancer care
Knowledge-focused CompletedThis study looked at whether combining detailed MRI scans with whole genome sequencing can help doctors choose the best treatment for people with liver cancer. Researchers studied 200 adults who were scheduled for liver surgery. The goal was to see if these advanced tests provide…
Sponsor: Perspectum • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
IBD patients at risk for eating disorders, study finds
Knowledge-focused CompletedThis study measured how often adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) show signs of eating disorders, including avoidant/restrictive food intake disorder (ARFID). Researchers used questionnaires to assess eating habits and nutritional status…
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could a simple nerve block shield kidneys during cancer surgery?
Knowledge-focused CompletedThis study looked at whether a nerve block called the erector spinae plane block can protect kidney function during laparoscopic colorectal cancer surgery. Sixty adults having this surgery were divided into two groups: one received the nerve block plus standard anesthesia, the ot…
Phase: NA • Sponsor: Kayseri City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New scoring system aims to better predict ulcerative colitis outcomes
Knowledge-focused CompletedThis study tested a new scoring system called CAT-DESIRE to evaluate ulcerative colitis severity using colonoscopy images. Researchers reviewed images from 235 patients to see if the new score is reliable and can predict long-term outcomes. The goal is to provide a simple, accura…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Study reveals Real-World choices in treating complicated diverticulitis
Knowledge-focused CompletedThis study looked at how 208 patients with severe diverticulitis were treated at a Brussels hospital network between 2015 and 2024. Researchers wanted to see which treatments doctors chose, such as medication alone, drainage, or different types of surgery. The goal was to underst…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Study reveals Long-Term career and school impacts of Early-Onset IBD
Knowledge-focused CompletedThis study looked at 343 adults who were diagnosed with inflammatory bowel disease (Crohn's disease or ulcerative colitis) before age 17. Researchers compared their employment rates and education levels to the general population to understand how the disease may affect long-term …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Distance to hospital may delay Life-Saving chemo for colon cancer patients
Knowledge-focused CompletedThis study looked at 140 patients who had colon cancer surgery and chemotherapy at Rouen University Hospital. The goal was to see if living farther from the hospital caused a longer wait to start chemotherapy after surgery. The findings could help improve care for patients who li…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
What do patients really think about colon tests? small study aims to find out
Knowledge-focused CompletedThis completed study interviewed 12 patients waiting for either a colonoscopy or a colon capsule endoscopy. The goal was to understand what factors are most important to them when deciding between these two colon tests. Researchers used telephone interviews and analyzed the conve…
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Gut antibody study aims to unlock Crohn's secrets
Knowledge-focused CompletedThis study looked at antibodies in the intestines of 160 people: 80 with Crohn's disease, 40 with ulcerative colitis, and 40 without inflammatory bowel disease. Researchers took blood samples and intestinal biopsies to compare antibody levels in the gut versus the blood. The goal…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New study seeks better ways to diagnose and predict inflammatory bowel disease
Knowledge-focused CompletedThis study looked at 366 adults referred for suspected inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The goal was to find simple, non-invasive markers that can help doctors diagnose IBD more accurately and predict how the disease will progres…
Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Gene study reveals clues about ulcerative colitis risk and drug effectiveness
Knowledge-focused CompletedThis study examined how differences in the BAFF gene might affect a person's risk of developing ulcerative colitis and how well they respond to the drug vedolizumab. Researchers analyzed genetic samples from 841 people with ulcerative colitis. The goal was to better understand th…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Researchers watch how IBD patients pick their vedolizumab shot or drip
Knowledge-focused CompletedThis study observed 165 people with inflammatory bowel disease (Crohn's or ulcerative colitis) in Poland who were already taking or starting vedolizumab. Researchers tracked whether patients chose intravenous or subcutaneous (under-the-skin) injections, and how long they stayed o…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Hidden Gut-Brain issues common in kids with IBD, study finds
Knowledge-focused CompletedThis completed Italian study looked at how often children with inactive inflammatory bowel disease (IBD) also have disorders of gut-brain interaction (DGBIs), like irritable bowel syndrome. Researchers used the Rome IV questionnaire to compare 220 children with quiescent IBD to h…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Healthy stool study aims to sharpen IBD diagnosis
Knowledge-focused CompletedThis study measured calprotectin, a protein in stool that signals gut inflammation, in 121 healthy adults aged 22 and older. Participants collected a single stool sample at home and mailed it in. The goal is to establish what level is normal, helping doctors better tell apart inf…
Sponsor: American Laboratory Products Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Decades of data reveal shifting surgery trends in kids with IBD
Knowledge-focused CompletedThis study reviewed medical records of 966 children diagnosed with Crohn's disease or ulcerative colitis between 1988 and 2011. Researchers looked at how often children needed surgery and how treatments like immunosuppressants and anti-TNF drugs were used over time. The goal was …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New biologics for Crohn's: do they work? study reveals clues
Knowledge-focused CompletedThis completed study from China looked at 50 adults with Crohn's disease who were treated with two newer biologic drugs, Ustekinumab and Vedolizumab. The goal was to see how well these drugs control the disease and what factors might predict a good response. By analyzing past med…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Kids with IBD: are they less fit than their peers?
Knowledge-focused CompletedThis study looked at physical fitness in 100 children and teens (ages 10-17) with chronic inflammatory bowel disease (Crohn's disease, ulcerative colitis, or unclassified colitis) and compared them to healthy kids of the same age, weight, and sex. Researchers measured cardiorespi…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study checks if IBD drug skyrizi seeps into breast milk
Knowledge-focused CompletedThis study looked at how much of the drug risankizumab (Skyrizi) passes into the breast milk of women with inflammatory bowel disease (IBD). Ten breastfeeding mothers who were already taking the drug provided milk samples over several weeks. The goal is to understand potential ex…
Phase: PHASE4 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Stool tests could make IBD monitoring easier and cheaper
Knowledge-focused CompletedThis study looked at 120 adults with inflammatory bowel disease (IBD) to see if simple stool tests can tell if the disease is active or in remission, just like a colonoscopy does. Colonoscopy is the current gold standard but is expensive, invasive, and not ideal for frequent chec…
Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Walnut wonder: daily snack may reshape gut bacteria and fight colon cancer
Knowledge-focused CompletedThis study looked at whether adding walnuts to your diet can change the bacteria in your gut and reduce signs of colon cancer risk. About 140 people at higher risk for colorectal cancer ate walnuts for a month. Researchers measured changes in gut bacteria, blood markers, and colo…
Phase: NA • Sponsor: UConn Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Could the pill ease IBD Flare-Ups? new study investigates
Knowledge-focused CompletedThis study looked at how hormonal birth control might help manage inflammatory bowel disease (IBD) symptoms that get worse during a woman's period. Researchers surveyed 50 women with IBD to understand their preferences for birth control and whether they would join a future trial.…
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Immune cell clues in colon cancer could forecast recurrence risk
Knowledge-focused CompletedThis study followed 56 patients who had surgery for non-metastatic colon cancer to see if the number and type of immune cells in their tumors could predict whether the cancer would come back. Researchers analyzed both blood samples and tumor tissue for various immune markers. The…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New genetic test may predict colon cancer return
Knowledge-focused CompletedThis study looked at whether a genetic test called QMPSF can help predict if stage II or III colon cancer will come back after surgery. Researchers analyzed tumor tissue from 401 patients for specific DNA changes. The goal was to see if these genetic markers are linked to cancer …
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Gene combo clues could spot High-Risk colon cancer families
Knowledge-focused CompletedThis study looks at whether certain combinations of genetic variations, rather than a single gene, can increase the risk of colorectal cancer. Researchers will compare the DNA of 700 patients with strong family histories of the disease against 350 healthy controls. The goal is to…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New biomarker may predict which cancer drugs work best
Knowledge-focused CompletedThis completed study tested whether a new biomarker called 'mass response' can predict how well a cancer therapy will work. Researchers collected tumor cells from 72 patients with various cancers through fluid drainage or biopsies. The goal was to see if this biomarker could guid…
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can genes predict colorectal cancer drug success?
Knowledge-focused CompletedThis study looked at 76 adults with advanced colorectal cancer to find genetic markers that might predict how well a combination of chemotherapy (FOLFOX) and the drug bevacizumab works. The goal was to understand which patients benefit most, not to test a new cure. Participants h…
Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Which position makes colonoscopy easier? new study investigates
Knowledge-focused CompletedThis study tested whether starting a colonoscopy with the patient lying on their back (supine) or on their left side (left-lateral) makes a difference. Researchers measured how long it took to complete the procedure, how much pain patients felt, and how difficult the procedure wa…
Phase: NA • Sponsor: Celal Bayar University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New study aims to help nurses talk about sex with men who have IBD
Knowledge-focused CompletedThis study aims to create a tool that helps nurses better assess and care for the sexual health needs of men with inflammatory bowel disease (IBD). The research involved 792 participants, including men with IBD and their partners, as well as healthcare professionals. The goal is …
Sponsor: York Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Protein PHGDH may predict immunotherapy success in colorectal cancer
Knowledge-focused CompletedThis completed study from West China Hospital examined tumor tissue from 100 colorectal cancer patients who had already received immunotherapy. Researchers measured levels of a protein called PHGDH to see if it was linked to how well the patients responded to treatment and how lo…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Can a simple lesson boost colon cancer screening rates?
Knowledge-focused CompletedThis study gave educational materials about colorectal cancer and screening to 188 adults aged 45-75 in the Tampa Bay area. Researchers used surveys to measure changes in knowledge and screening intentions. The goal was to see if education encourages people to talk to their docto…
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
AI and balloon scope team up to spot more polyps in colon cancer screening
Knowledge-focused CompletedThis study looked at whether using a special balloon-assisted scope (G-Eye) together with artificial intelligence (CAD-Eye) finds more polyps than a standard colonoscopy with AI alone. About 300 people aged 50-74 who had a positive stool test took part. The goal was to see if the…
Sponsor: Elsan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Emergency surgery in pregnancy: new study aims to understand fetal outcomes
Knowledge-focused CompletedThis study looked at how emergency general surgery affects pregnant women and their unborn babies. Researchers planned to follow pregnant women who needed surgery for problems like appendicitis or gallbladder disease. The goal was to learn more about the safety of these surgeries…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Muscle loss linked to worse surgery outcomes in colorectal cancer patients
Knowledge-focused CompletedThis study looked at 70 adults with colorectal cancer to see how common muscle loss (sarcopenia) is before surgery and whether it leads to more complications or longer hospital stays. Researchers measured muscle strength, mass, and physical performance. The goal is to find patien…
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Biomarkers may guide personalized pain relief for kids
Knowledge-focused CompletedThis study looked at 163 children aged 7-12 with chronic abdominal pain to see if simple tests (biomarkers) could predict whether they would benefit more from cognitive behavioral therapy (CBT) or a low FODMAP diet. The goal was to personalize treatment and improve symptoms and q…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New blood test could spare colon cancer patients unnecessary chemo
Knowledge-focused CompletedThis completed study tested a blood test that looks for tiny cancer leftovers after surgery in 175 people with stage II or III colorectal cancer. The goal was to see if the test could identify who really needs chemotherapy. If it works, it could help personalize treatment and avo…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Antibiotics may temporarily alter gut nerve cells, new study finds
Knowledge-focused CompletedThis study looked at how a short course of antibiotics changes the nerve and glia cells in the lower gut of 10 healthy adults. Researchers took colon tissue samples before and after antibiotic treatment to count these cells and measure gene activity. The goal was to understand if…
Phase: PHASE4 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Are IBD drugs safe in pregnancy? large french study investigates
Knowledge-focused CompletedThis study analyzed data from over 8,700 pregnant women with inflammatory bowel disease (Crohn's or ulcerative colitis) to see how well doctors follow guidelines when prescribing antiTNFα drugs and whether the benefits outweigh the risks for both mother and baby. Researchers look…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can surgery go green? study measures carbon footprint of appendix removal
Knowledge-focused CompletedThis study looked at how sustainable laparoscopic appendectomy is by measuring its environmental impact (carbon emissions), cost, and health benefits. Researchers followed 63 patients in Chile who had surgery for acute appendicitis. The goal was to create a single score that comb…
Sponsor: Universidad de La Frontera • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
AI learns from 600 colonoscopies to spot polyps
Knowledge-focused CompletedThis study gathered real-world videos and images from 600 adults undergoing screening or surveillance colonoscopies. The data will be used to develop and test artificial intelligence systems that can help doctors detect colon polyps. The study is complete and focused on data coll…
Sponsor: Olympus Europe SE & Co. KG • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Which scope spots trouble better? study tests two colonoscopy techniques for IBD patients
Knowledge-focused CompletedThis study looked at 211 adults with long-standing inflammatory bowel disease (IBD) to see which colonoscopy method finds precancerous growths better: high-definition white light or dye spraying. Participants had IBD for at least eight years. The goal was to improve cancer screen…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Study reveals hidden risks for polyp regrowth after colonoscopy
Knowledge-focused CompletedThis study reviewed the medical records of 255 adults who had colorectal polyps removed during a colonoscopy. The goal was to find out which factors, such as how the polyp was removed or its tissue type, make it more likely to come back. Researchers also tracked any complications…
Sponsor: University of Sao Paulo • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Second chance surgery for rectal cancer: what predicts success?
Knowledge-focused CompletedThis study looked at 143 people in China who had a second surgery after rectal cancer treatment because of a leak or tumor return. Researchers wanted to find out what factors help the surgery succeed and whether patients can regain the ability to poop normally. The goal is to bet…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New device aims to sharpen polyp measurements for trainee doctors
Knowledge-focused CompletedThis study tested a device called Napoleon to help gastroenterology fellows measure colon polyps more accurately during colonoscopies. 46 patients aged 45 and older participated. The goal was to see if using the device improves measurement accuracy compared to just looking, which…
Phase: EARLY_PHASE1 • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Patch vs. pill: new ozanimod skin patch tested in healthy volunteers
Knowledge-focused CompletedThis study tested a new way to deliver the drug ozanimod using a skin patch instead of oral capsules. 24 healthy adults either took one capsule or wore a patch for 7 days. Researchers measured drug levels in the blood and checked for skin reactions to see if the patch works well …
Sponsor: Corium Innovations, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Can a simple dye prevent deadly leaks after colon cancer surgery?
Knowledge-focused CompletedThis study looked at whether using a special dye (indocyanine green) during laparoscopic surgery for colon or rectal cancer can help surgeons see blood flow in real time and reduce the risk of a dangerous leak where the bowel is reconnected. Researchers compared 115 patients who …
Sponsor: Jagiellonian University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood test may help overcome barriers to colon cancer screening
Knowledge-focused CompletedThis completed study with 297 participants examined if offering a blood-based screening test (Guardant Shield) encourages people who previously avoided stool tests or colonoscopy to get screened for colorectal cancer. Participants were adults aged 45-75 at average risk who had no…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Hidden virus in Kids' guts: new study sheds light on CMV and IBD
Knowledge-focused CompletedThis study looked at 139 children having a colonoscopy to see how often the CMV virus is found in their gut tissue and blood. Some children had inflammatory bowel disease (Crohn's or colitis) and some did not. The goal was to learn which tests best detect CMV in the gut, helping …
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Can a picture help you understand your genetic risk?
Knowledge-focused CompletedThis study tested how well people understand genetic risk when shown different visual aids. Over 1,000 participants viewed either a single side-by-side chart or a step-by-step narrative with pictures. They then estimated their risk and answered questions about how they felt and w…
Phase: NA • Sponsor: Stephanie B. Seminara, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Timing is everything: study links treatment delays to colorectal cancer survival
Knowledge-focused CompletedThis study looked at 227 people with colorectal cancer that had spread to the lining of the belly. Researchers wanted to see if waiting longer between chemotherapy and surgery affected how long patients lived without the cancer coming back. The goal is to find the best timing for…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Gene clues could personalize ulcerative colitis treatment
Knowledge-focused CompletedThis completed study examined whether differences in the IL-7 receptor gene are linked to the risk of developing ulcerative colitis and how well patients respond to the drug vedolizumab. Researchers enrolled 898 people, including those with UC and healthy controls, and analyzed t…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Can a recovery checklist help appendix patients go home sooner?
Knowledge-focused CompletedThis study observed 193 adults who had emergency laparoscopic appendix surgery for uncomplicated appendicitis. Researchers wanted to see how closely hospitals followed a specific recovery plan called RICA (an ERAS pathway) and whether early discharge within 24 hours was safe and …
Sponsor: Hospital Galdakao-Usansolo • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Which colon cancer surgery is better? new study compares techniques
Knowledge-focused CompletedThis study compared two types of laparoscopic surgery for early-stage colon cancer: conventional colectomy and complete mesocolic excision (CME). Researchers looked at 150 patients in Upper Egypt to see which surgery removed more lymph nodes and caused fewer complications. The go…
Phase: NA • Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New lymph node map could sharpen colon cancer prognosis
Knowledge-focused CompletedThis completed study analyzed data from 1,500 colon cancer patients to see if a new way of classifying lymph node involvement—based on both the number and location of affected nodes and tumor deposits—can better predict survival than the current standard system. Researchers colle…
Sponsor: Cai Zerong • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
10-Year study sheds light on best surgical approach for kids with severe appendicitis
Knowledge-focused CompletedThis study looked back at 765 children with complicated appendicitis treated over ten years. Researchers wanted to see how well laparoscopic surgery works for different types of the condition, including cases with abscess or mass. The goal is to help doctors decide the best treat…
Phase: NA • Sponsor: Mohammad Daboos • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Early safety check for new c. diff drug in japanese volunteers
Knowledge-focused CompletedThis early-stage study tested a single dose of AZD5148, a potential treatment for C. difficile infection, in 16 healthy Japanese adults. The main goal was to see if the drug is safe and how the body processes it. Participants received either the drug or a placebo by injection and…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Colombian study reveals gaps in appendicitis scoring tool use
Knowledge-focused CompletedThis study looked at how often emergency room doctors in Villavicencio, Colombia, use a tool called the Alvarado score to help diagnose appendicitis. The researchers surveyed 125 doctors to see if they knew about the score, used it, and wrote it down for patients with belly pain.…
Sponsor: Hospital Departamental de Villavicencio • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Massive study aims to settle debate on colon cancer surgery extent
Knowledge-focused CompletedThis completed study followed over 3,600 people with stage I to III colon cancer who had surgery. The goal was to learn how far cancer spreads to lymph nodes and how much bowel and tissue should be removed for the best outcome. The results could help guide surgeons in the future,…
Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Faith and health: church program tackles latino cancer trial gap
Knowledge-focused CompletedThis study tested whether an educational session at a church could help Latino adults learn more about colorectal cancer and feel more willing to join cancer clinical trials. Sixty Spanish-speaking participants watched videos and completed surveys. The goal was to understand barr…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
AI boosts polyp detection in colonoscopy: over 5,000 tested
Knowledge-focused CompletedThis completed study tested whether an AI system called GI Genius helps doctors spot polyps during colonoscopy. Over 5,000 adults participated. The goal was to see if AI improves detection rates and whether using AI has a lasting learning effect. Results could lead to better colo…
Phase: NA • Sponsor: Haraldsplass Deaconess Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New RNA tool may reveal best heated chemo for rare abdominal cancer
Knowledge-focused CompletedThis completed study tested a new method to see how well two different heated chemotherapy regimens work against pseudomyxoma peritonei, a rare abdominal cancer. Researchers injected a special form of chemotherapy (5-FU) before surgery to label newly made RNA in tumor cells. Afte…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Simple blood test may spot severe appendicitis faster
Knowledge-focused CompletedThis study looked at whether high bilirubin levels in the blood can help doctors quickly tell if appendicitis is complicated. Researchers studied 400 people who had their appendix removed. The goal was to see if this cheap, fast test could help doctors make better decisions about…
Sponsor: Minia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Real-World study tracks how IBD patients choose between IV and injectable vedolizumab
Knowledge-focused CompletedThis study observed 92 adults with Crohn's disease or ulcerative colitis who were receiving vedolizumab either as an intravenous infusion or a subcutaneous injection. Researchers tracked treatment patterns, such as whether patients stayed on their current form or switched, over 1…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
IBD patients face hidden oral health struggles, study reveals
Knowledge-focused CompletedThis study looked at how inflammatory bowel disease (IBD) affects oral health and daily life. Researchers compared 138 adults with IBD to people without IBD, using a questionnaire to measure oral health-related quality of life. The goal was to understand which factors, like medic…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New index may predict death risk after abdominal surgery infection
Knowledge-focused CompletedThis study tested whether the Capillary Leak Index (CLI), a score based on routine blood tests, can predict which patients are at higher risk of dying after developing a serious abdominal infection following surgery. Researchers followed 100 critically ill adults in the ICU for 2…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Scientists uncover DNA's hidden role in Kids' gut disease
Knowledge-focused CompletedThis study looked at 40 children aged 6 to 17 with inflammatory bowel disease (Crohn's or ulcerative colitis) to understand how DNA that escapes from cells might make inflammation worse. Researchers analyzed blood, stool, and gut tissue samples to see if a specific pathway (cGAS-…
Phase: NA • Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Texting beats calling for colon cancer tests
Knowledge-focused CompletedThis study tested whether sending text message reminders helps more people complete a take-home colon cancer screening test (FIT) compared to standard phone call reminders. Over 1,200 adults from NYU family health centers took part. Researchers tracked how many completed the test…
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Can your immune system predict a c. diff relapse?
Knowledge-focused CompletedThis study looked at how the immune system responds to Clostridium difficile infection in hospitalized patients. Researchers took blood samples every two days to measure immune markers. The goal was to find out why some patients have repeat infections. The study involved 56 parti…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Tiny study aims to improve c. diff sample collection
Knowledge-focused CompletedThis study looked at how well stool and blood samples could be collected from 7 adults with an active C. diff infection. Researchers wanted to see if the collection, shipping, and testing methods worked smoothly. Participants also filled out questionnaires about their symptoms. T…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Bacteria in mouth and gut may hold clues to colon polyp risk
Knowledge-focused CompletedThis study looked at the bacteria in the mouth and gut of 126 people with and without serrated polyposis syndrome, a condition that raises the risk of colorectal cancer. Researchers compared the bacteria in people with the syndrome to those with other types of polyps or no polyps…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
8,000 volunteers help uncover colon polyp risks
Knowledge-focused CompletedThis study looked at why some people develop colorectal polyps (growths that can turn into cancer) and others do not. Researchers collected blood, urine, saliva, and tissue samples from over 8,000 adults getting a colonoscopy. They also gathered information about lifestyle and he…
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Knot or clip? study tests best way to seal the appendix after removal
Knowledge-focused CompletedThis completed trial looked at 190 people having laparoscopic appendix removal. It compared closing the appendix stump with a hand-tied knot versus a plastic clip. The goal was to see which method leads to fewer problems like infection or slow bowel recovery within 15 days after …
Phase: EARLY_PHASE1 • Sponsor: Punjab Health Care Commission • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Can a website and text messages help colon cancer survivors eat better?
Knowledge-focused CompletedThis study tested a 12-week web-based diet program with text messages for 50 colorectal cancer survivors. The goal was to see if survivors would use the program and if it could help them eat healthier. The study did not test whether the diet changes actually prevent cancer from c…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Your iPhone could be your next cancer symptom tracker
Knowledge-focused CompletedThis study tested whether iPhones and Apple Watches can reliably collect health data from people with cancer. 49 adults undergoing cancer treatment wore an Apple Watch and used an iPhone for 4 months to track activity, fatigue, and thinking skills. The goal was to see if these de…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Cancer patients speak out: what they really want from pharmacy visits
Knowledge-focused CompletedThis study asked 167 people with cancer (and their caregivers) what they value most during pharmacy consultations for oral cancer drugs. Using a survey method, researchers identified key preferences to help hospitals design better support services. The goal was to improve patient…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New study tracks colon cancer return rates after advanced surgery
Knowledge-focused CompletedThis study looked at how often colon cancer came back within 5 years after a specific type of surgery called Laparoscopic Complete Mesocolic Excision (LCME). Researchers followed over 2,500 patients in Denmark who had stage I, II, or III colon cancer. The goal was to understand r…
Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Immune cell training may lead to new cancer therapies
Knowledge-focused CompletedThis completed study examined how immune cells (myeloid cells and their bone marrow progenitors) change in patients with newly diagnosed thyroid or colon cancer. Researchers measured inflammatory markers before and after exposing cells to agents that could 'train' them to fight t…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Scientists map immune cells in colon cancer patients
Knowledge-focused CompletedThis completed study looked at immune cells in the blood and tumor tissue of 100 people with colon cancer. Researchers measured T cells and other white blood cells to understand the body's immune response. The goal was to gather knowledge, not to test a new treatment. Participant…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
App with rewards boosts cancer screening decisions in pilot trial
Knowledge-focused CompletedThis study tested a smartphone app that uses quizzes and rewards to help people make informed choices about colorectal cancer screening. 248 adults in Italy were randomly assigned to use either the gamified app or a basic information app. The researchers measured whether particip…
Phase: NA • Sponsor: University of Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Smart devices track cancer recovery at home
Knowledge-focused CompletedThis study tested whether using at-home monitoring devices (like a wristband pedometer, scale, and blood pressure cuff) can help improve care for cancer patients after they leave the hospital following surgery. 22 patients with various cancers participated. The goal was to see if…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Gene clues could personalize Crohn's treatment
Knowledge-focused CompletedThis study looked at 818 people with Crohn's disease to see if variations in the TNFSF4 gene are linked to the disease and how well patients respond to the drug ustekinumab. Researchers analyzed blood samples to find genetic patterns. The goal is to better understand why some pat…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Colon cancer clues: DNA repair status may guide surgery decisions
Knowledge-focused CompletedThis completed study looked at 1,471 colon cancer patients to see how their tumor's DNA repair status (pMMR vs dMMR) relates to lymph node spread and survival. Researchers hope to identify patients who might not need extensive lymph node removal. The study is observational and do…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Study reveals best ways to adjust ulcerative colitis treatment for better living
Knowledge-focused CompletedThis study looked at 234 adults with ulcerative colitis whose gut lining had healed (Mayo 0 or 1). Researchers tracked how increasing, decreasing, or switching treatments affected patients' quality of life over 6 and 12 months. They also measured inflammation markers like fecal c…
Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Pre-Surgery blood vessel block may boost colon healing
Knowledge-focused CompletedThis small pilot study tested whether blocking the inferior mesenteric artery with tiny particles 3-4 weeks before rectal or sigmoid colon cancer surgery helps the colon develop extra blood vessels. The goal was to see if this improves blood flow and oxygen supply to the colon du…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
DNA levels in blood tracked during cancer operations
Knowledge-focused CompletedThis study looked at how DNA from tumors changes in the blood before, during, and after surgery for breast, prostate, or colon cancer. Thirty adults having curative surgery provided blood samples to measure these DNA levels. The goal was to understand the natural pattern of DNA c…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Lab-Grown mini guts shed light on bowel disease
Knowledge-focused CompletedThis study looked at tiny, lab-grown versions of the intestine called organoids, made from tissue samples of people with inflammatory bowel disease (Crohn's or ulcerative colitis), a genetic polyp condition (FAP), and healthy volunteers. The goal was to understand how intestinal …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Timing matters: when to first assess symptoms in UC treatment?
Knowledge-focused CompletedThis completed study from Xijing Hospital looked at 180 adults with mild-to-moderate ulcerative colitis starting 5-ASA therapy. Researchers compared checking symptoms at 4, 8, or 12 weeks to see which timing best predicted treatment success at 48 weeks. The goal was to help docto…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Does the flu shot work in IBD patients on immune drugs?
Knowledge-focused CompletedThis study tested how well the flu vaccine works and if it's safe for people with inflammatory bowel disease (IBD). Researchers compared 228 adults with IBD who were either taking immunosuppressive drugs or not. The goal was to see if the vaccine triggers a strong immune response…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Mindfulness may cut colon cancer risk in High-Stress communities
Knowledge-focused CompletedThis pilot study tested whether a mindfulness program could help reduce colorectal cancer risk factors in Black women aged 45-65 who live in high-crime Chicago neighborhoods and have had a colon polyp. Twenty-four women participated to see if the program was feasible and acceptab…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
666 patients help doctors find best appendix closure method
Knowledge-focused CompletedThis study looked at different methods for closing the appendix stump after surgery for complicated appendicitis. Researchers compared how often leaks happened with each technique. The study included 666 adults aged 18 and older with complicated appendicitis.
Sponsor: Zagazig University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Cancer patients test decision tools: timing matters?
Knowledge-focused CompletedThis study looked at whether giving cancer patients a decision aid before their doctor visit (on a smartphone) or during the visit (on paper) helps them feel more involved in treatment decisions. 274 adults with breast or colorectal cancer took part. The goal was to see which for…
Phase: NA • Sponsor: Vejle Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Blood test scores may predict UC attacks, study finds
Knowledge-focused CompletedThis study looked at whether two blood-based scores (CALLY and HAALP) can help doctors tell when ulcerative colitis is active. Researchers measured these scores in 100 patients and compared them to standard inflammation markers. The goal was to see if these scores could be a simp…
Sponsor: Ataturk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Which drug first? Real-World study aims to optimize colorectal cancer treatment sequence
Knowledge-focused CompletedThis completed observational study examined the real-world use of two approved drugs, regorafenib and TAS-102 (sometimes with bevacizumab), in 818 adults with metastatic colorectal cancer that had stopped responding to other treatments. Researchers analyzed electronic health reco…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
What makes people get screened? study reveals best colon cancer messages
Knowledge-focused CompletedThis study looked at which online messages about colon cancer screening are most convincing and likely to be shared. Over 2,200 Black and White Americans aged 45-74 rated different messages from websites. The goal was to find the best ways to encourage people to follow screening …
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to boost cancer screening among american indians
Knowledge-focused CompletedThis study worked with American Indian communities in New Mexico to find better ways to encourage screening for breast, colon, and cervical cancers. Over 500 adults took part in focus groups, surveys, and pilot programs. The goal was to understand barriers and test simple educati…
Phase: NA • Sponsor: New Mexico Cancer Research Alliance • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Mapping blood flow after rectal cancer surgery: a step toward safer operations
Knowledge-focused CompletedThis study involved 89 patients with distal sigmoid or rectal cancer who underwent standard surgery with high ligation of the inferior mesenteric artery. Researchers used CT scans before and after surgery to map blood flow paths and check if their planned routes matched reality. …
Sponsor: Shandong First Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Hidden clues in gut tissue may predict ulcerative colitis Flare-Ups
Knowledge-focused CompletedThis study looked at 159 people with ulcerative colitis who started a new advanced therapy. Researchers examined tissue samples from the colon to see if microscopic signs of inflammation could predict future problems like hospital stays or surgery. The goal is to help doctors dec…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Which position is best for a rectal exam? study seeks answer
Knowledge-focused CompletedThis study compared two common positions for a digital rectal exam: lying on your side (lateral decubitus) versus lying on your back (supine). The goal was to see which position allows doctors to perform a more complete exam. The study involved 320 men with conditions like colon …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:17 UTC
-
Nurse coordinator may boost recovery plan compliance in colorectal surgery
Knowledge-focused CompletedThis study tested whether having a nurse coordinator (NEC) helps patients follow the Enhanced Recovery After Surgery (ERAS) program after colorectal surgery. Over 200 patients from multiple hospitals took part, with one group having the nurse and the other not. The goal was to se…
Phase: NA • Sponsor: Hospital Universitari de Bellvitge • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:01 UTC
-
Mini organs from biopsies could revolutionize gut disease research
Knowledge-focused CompletedThis study takes small tissue samples from people with inflammatory bowel disease (IBD) and healthy volunteers to grow 'mini guts' (organoids) in the lab. Researchers will then expose these organoids to radiation to mimic radiation enteritis and test potential treatments. The goa…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:33 UTC
-
Massive study of 7,259 colon cancer patients reveals recurrence patterns after surgery
Knowledge-focused CompletedThis study looked back at over 7,000 colon cancer patients who had surgery to remove their tumors. Researchers wanted to see how the cancer's stage and lymph node involvement affected whether the cancer came back and how long patients lived. By grouping patients by tumor and node…
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:09 UTC
-
Toxicology study sheds light on chemical submission cases
Knowledge-focused CompletedThis completed study looked at 100 people who reported a suspected chemical submission (being secretly given drugs). Researchers performed detailed toxicology tests on blood and urine samples to find out which substances were present. The goal was to confirm how many cases involv…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:06 UTC
-
AI timer boosts polyp detection during colonoscopy
Knowledge-focused CompletedThis study tested whether an artificial intelligence system that tracks how long doctors spend examining the colon during a colonoscopy could help them find more polyps. Researchers enrolled 193 adults aged 40 and older undergoing outpatient colonoscopy. The AI calculated effecti…
Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:46 UTC
-
Hospitals checked: are they following best recovery practices for colon surgery?
Knowledge-focused CompletedThis completed study looked at how closely eight hospitals in Rome followed Enhanced Recovery After Surgery (ERAS) protocols for 1,000 patients having colorectal surgery. ERAS is a set of steps designed to help patients recover faster after surgery. The researchers wanted to see …
Sponsor: PERSIANI ROBERTO • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:03 UTC
-
Vitamin B3 study explores how body handles supplement during illness
Knowledge-focused CompletedThis completed study looked at how a special form of vitamin B3 (nicotinamide) is processed in 28 patients with low tryptophan levels due to respiratory infections or inflammatory bowel disease. Participants took either 500 mg or 1000 mg of the supplement daily for four weeks. Th…
Phase: NA • Sponsor: University Hospital Schleswig-Holstein • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:47 UTC
-
AI magic: can doctors spot fake colonoscopy images?
Knowledge-focused CompletedThis study tested an AI system called EndoStyle that can change the style of colonoscopy images to look like they came from different video processors. 40 doctors with colonoscopy experience were shown sequences of real and AI-transformed images to see if they could tell the diff…
Sponsor: Wuerzburg University Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:34 UTC